Content by The Lancet
|5 min read
Breast Cancer Remains the Most Common Cancer in Women, with Cases Projected to Exceed 3.5 Million by 2050
Six modifiable risks drive over a quarter of healthy years lost to breast cancer
|5 min read
Cancer Deaths Expected to Rise to over 18 Million in 2050—an Increase of Nearly 75 percent from 2024
Over 40 percent of cancer deaths globally are linked to 44 modifiable risk factors, presenting an opportunity for prevention
|5 min read
Global, Equitable Distribution of Safe COVID-19 Vaccines Is Imperative
COVID-19 vaccination potential won't be achieved without increased production, affordable pricing, global availability, and successful rollout
|5+ min read
Phase 3 Trials Show Oxford COVID-19 Vaccine Is Safe and Protects against Disease
The first clinical efficacy results of the vaccine are based on a pre-specified pooled analysis of phase 3 trials in the UK and Brazil
|3 min read
Phase 2 Trial of Oxford COVID-19 Vaccine in Older Adults Finds It Is Safe
Robust antibody and T-cell response seen in older adults is encouraging
|5 min read
Study: Expect Surge in HIV, TB, and Malaria Deaths Due to Pandemic
Some low- and middle-income countries could see HIV, TB, and malaria deaths increase by as much as 10, 20, and 36 percent respectively over the next five years
|4 min read
First Human Trial of COVID-19 Vaccines Finds It Is Safe, Induces Rapid Immune Response
The creation of an effective vaccine is seen as the long-term solution to controlling the COVID-19 pandemic
|4 min read
Study Details First Known Person-To-Person Transmission of New Coronavirus in the US
Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while the first patient was symptomatic
|4 min read
New Coronavirus Cannot Be Passed from Mother to Child Late in Pregnancy
A small observational study of women from Wuhan, China, showed no adverse outcomes in neonates or that the virus can pass to the child while in the womb
|1 min read
Coronavirus: New Report Provides Largest Clinical and Treatment Data Set
Analysis includes 99 patients with laboratory-confirmed 2019 novel coronavirus
|4 min read
Fewer Than Half of US Clinical Trials Have Complied with Law on Reporting Results
Only 41 percent of clinical trial results are reported promptly onto the US trial registry, and one in three trials remain unreported, according to the first comprehensive study of compliance since new US regulations came into effect in January 2017
|5+ min read
